This episode features Stanford Professor and transplant surgeon Dr. Stephan Busque. He discusses his extensive experience in the field of tolerance in transplantation, particularly focusing on advancements over the past 20 years. Dr. Busque highlights the significance of his team's work on translating research into clinical practice and mentions that they have the largest experience globally in this field.
Additionally, Dr. Busque shares exciting news about Stanford's first allogenic islet cell transplantation for a patient with type one diabetes, indicating a collaborative effort that brought together a multidisciplinary team to achieve this milestone. He reflects on the journey of making islet cell transplants more accessible and expresses hope for new beginnings in this area.
The episode wraps up with a lightning round where Dr. Busque discusses the qualities he admires in skilled surgeons, emphasizing the importance of being a well-rounded doctor who not only excels in technical skills but also demonstrates a deep understanding of patient care and connection. Going forward he’s excited for the development of protocols for various transplant scenarios, including open liver transplant tolerance, and indicates that patients with less-than-perfect matches are the next target group for improvements in transplantation techniques
All content for Scrubcast is the property of Stanford Surgery and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode features Stanford Professor and transplant surgeon Dr. Stephan Busque. He discusses his extensive experience in the field of tolerance in transplantation, particularly focusing on advancements over the past 20 years. Dr. Busque highlights the significance of his team's work on translating research into clinical practice and mentions that they have the largest experience globally in this field.
Additionally, Dr. Busque shares exciting news about Stanford's first allogenic islet cell transplantation for a patient with type one diabetes, indicating a collaborative effort that brought together a multidisciplinary team to achieve this milestone. He reflects on the journey of making islet cell transplants more accessible and expresses hope for new beginnings in this area.
The episode wraps up with a lightning round where Dr. Busque discusses the qualities he admires in skilled surgeons, emphasizing the importance of being a well-rounded doctor who not only excels in technical skills but also demonstrates a deep understanding of patient care and connection. Going forward he’s excited for the development of protocols for various transplant scenarios, including open liver transplant tolerance, and indicates that patients with less-than-perfect matches are the next target group for improvements in transplantation techniques
Getting to Know Acute Care Surgery & Dr. Morad Hameed
Scrubcast
19 minutes 59 seconds
1 year ago
Getting to Know Acute Care Surgery & Dr. Morad Hameed
In this episode of Scrubcast, host Rachel Baker interviews Dr. Morad Hameed, who recently joined Stanford as the chief of acute care surgery. They discuss Dr. Hameed's transition to Stanford, differences between Canadian and U.S. healthcare systems, and what drew Dr. Hameed to trauma surgery. Dr. Hameed shares an exciting trauma case and explains the nuances of trauma, emergency general surgery, and surgical critical care. The conversation also touches on Dr. Hamid's experiences in leadership roles, global surgery projects, and advice from mentors.
00:00 Introduction to Scrubcast and Guest Dr. Morad Hameed
00:24 Dr. Hameed's Journey to Stanford
01:41 Comparing U.S. and Canadian Healthcare Systems
03:29 The Fascination with Trauma Surgery
05:03 Memorable Trauma Cases
07:37 Understanding Acute Care Surgery
10:06 Leadership and Administrative Roles in Surgery
12:15 Global Surgery and Public Health
14:23 Inspirational Figures and Advice
18:41 What's Next for Dr. Hameed?
19:29 Conclusion and Credits
Scrubcast
This episode features Stanford Professor and transplant surgeon Dr. Stephan Busque. He discusses his extensive experience in the field of tolerance in transplantation, particularly focusing on advancements over the past 20 years. Dr. Busque highlights the significance of his team's work on translating research into clinical practice and mentions that they have the largest experience globally in this field.
Additionally, Dr. Busque shares exciting news about Stanford's first allogenic islet cell transplantation for a patient with type one diabetes, indicating a collaborative effort that brought together a multidisciplinary team to achieve this milestone. He reflects on the journey of making islet cell transplants more accessible and expresses hope for new beginnings in this area.
The episode wraps up with a lightning round where Dr. Busque discusses the qualities he admires in skilled surgeons, emphasizing the importance of being a well-rounded doctor who not only excels in technical skills but also demonstrates a deep understanding of patient care and connection. Going forward he’s excited for the development of protocols for various transplant scenarios, including open liver transplant tolerance, and indicates that patients with less-than-perfect matches are the next target group for improvements in transplantation techniques
